Abstract

Adjuvants are indispensable for achieving a sufficient immune response from vaccinations. From a functional viewpoint, adjuvants are classified into two categories: “physical adjuvants” increase the efficacy of antigen presentation by antigen-presenting cells (APC) and “signal adjuvants” induce the maturation of APC. Our previous study has demonstrated that a physical adjuvant can be encrypted into proteinous antigens by creating artificial proteins from combinatorial assemblages of epitope peptides and those peptide sequences having propensities to form certain protein structures (motif programming). However, the artificial antigens still require a signal adjuvant to maturate the APC; for example, co-administration of the Toll-like receptor 4 (TLR4) agonist monophosphoryl lipid A (MPLA) was required to induce an in vivo immunoreaction. In this study, we further modified the previous artificial antigens by appending the peptide motifs, which have been reported to have agonistic activity for TLR4, to create “adjuvant-free” antigens. The created antigens with triple TLR4 agonistic motifs in their C-terminus have activated NF-κB signaling pathways through TLR4. These proteins also induced the production of the inflammatory cytokine TNF-α, and the expression of the co-stimulatory molecule CD40 in APC, supporting the maturation of APC in vitro. Unexpectedly, these signal adjuvant-encrypted proteins have lost their ability to be physical adjuvants because they did not induce cytotoxic T lymphocytes (CTL) in vivo, while the parental proteins induced CTL. These results confirmed that the manifestation of a motif’s function is context-dependent and simple addition does not always work for motif-programing. Further optimization of the molecular context of the TLR4 agonistic motifs in antigens should be required to create adjuvant-free antigens.

Highlights

  • The immunomodulatory adjuvant is a critical component of a vaccine because it induces the cellular immune response to antigens, which are generally far less immunogenic

  • HEK-Blue cells containing the secreted embryonic alkaline phosphatase (SEAP) reporter were induced by both NF-κB and activator protein-1 (AP-1) transcription factors, and we showed that antigens B39 and B3931 have

  • We showed that artificial antigens with Toll-like receptor 4 (TLR4) agonistic motifs could modulate the maturation of antigen-presenting cells (APC) represented by the expression of inflammatory cytokine TNF-α and the surface maturation marker CD40

Read more

Summary

Introduction

The immunomodulatory adjuvant is a critical component of a vaccine because it induces the cellular immune response to antigens, which are generally far less immunogenic. The physical adjuvant includes inorganic materials such as mineral oil or aluminum salt and assists both the uptake of antigens by antigen-presenting cells (APC) and the proficient induction of an immune response, which requires a T-cell receptor (TCR) and major histocompatibility complex (MHC)/peptide interaction. Aluminum salt such as Alum is used as a physical adjuvant in many human vaccines, this adjuvant is limited to stimulating Th2-biased antibody responses, which may be inappropriate for the induction of cellular immunity against cancer [3, 4]. MPLA is less toxic than LPS and has been clinically used as an adjuvant for cancer vaccines [5, 9]

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call